Why the study?
Does a single 2 g intravenous dose of cefazolin prevent infective complications in patients undergoing pacemaker implantation or replacement?
Does a single 2 g intravenous dose of cefazolin prevent infective complications in patients undergoing pacemaker implantation or replacement?
A single 2 g intravenous dose of cefazolin prior to pacemaker implantation or replacement is associated with a very low rate of long-term infective complications.
No takes yet. Share an insight, caveat, or question.
Supports single-dose cefazolin prophylaxis in device implantation; leaves open need for randomized confirmation of infection prevention.
Bertaglia et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: